Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis

Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis

Background Reactivation of hepatitis B virus (HBV) replication is a well-recognised complication in patients receiving disease-modifying anti-rheumatic drugs (DMARDs) for rheumatoid arthritis (RA). Limited data exist on HBV reactivation among patients with RA treated with janus kinase (JAK) inhibito...

Full description

Saved in:
Bibliographic Details
Main Authors: Gerd Burmester, Tsutomu Takeuchi, Josef S Smolen, Mark C Genovese, Masayoshi Harigai, Kevin Winthrop, Yi-Ming Chen, Tsu-Yi Hsieh, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao
Format: Article
Language:English
Published: BMJ Publishing Group 2020-02-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/6/1/e001095.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rmdopen.bmj.com/content/6/1/e001095.full

Similar Items